134 related articles for article (PubMed ID: 17160771)
1. [Acute coronary syndrome: when an indication for clopidogrel?].
Köster R
Dtsch Med Wochenschr; 2006 Dec; 131(50):2864. PubMed ID: 17160771
[No Abstract] [Full Text] [Related]
2. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
[No Abstract] [Full Text] [Related]
3. [New guidelines in acute coronary syndrome. Clopidogrel for nine months is recommended].
MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440296
[No Abstract] [Full Text] [Related]
4. [Dual platelet inhibition with clopidogrel and ASS. Who profits from the combination?].
MMW Fortschr Med; 2003 Jul; 145(27-28):64. PubMed ID: 14587200
[No Abstract] [Full Text] [Related]
5. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
[TBL] [Abstract][Full Text] [Related]
6. [In acute coronary syndrome. Seize platelets with pliers].
MMW Fortschr Med; 2002 Nov; 144(45):61. PubMed ID: 12534069
[No Abstract] [Full Text] [Related]
7. [Acute coronary syndrome. The second platelet inhibitor is self-paid].
MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866304
[No Abstract] [Full Text] [Related]
8. The year in non-ST-segment elevation acute coronary syndromes.
Giugliano RP; Braunwald E
J Am Coll Cardiol; 2006 Jul; 48(2):386-95. PubMed ID: 16843191
[No Abstract] [Full Text] [Related]
9. [After coronary intervention. Which platelet inhibitor for whom?].
Stiefelhagen P
MMW Fortschr Med; 2007 Apr; 149(14):18-9. PubMed ID: 17668756
[No Abstract] [Full Text] [Related]
10. Dosing of clopidogrel and aspirin in acute coronary syndromes.
Merella P; Casu G; Meloni I
N Engl J Med; 2010 Dec; 363(25):2466-7; author reply 2467-8. PubMed ID: 21158665
[No Abstract] [Full Text] [Related]
11. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
Wiviott SD; Trenk D; Frelinger AL; O'Donoghue M; Neumann FJ; Michelson AD; Angiolillo DJ; Hod H; Montalescot G; Miller DL; Jakubowski JA; Cairns R; Murphy SA; McCabe CH; Antman EM; Braunwald E;
Circulation; 2007 Dec; 116(25):2923-32. PubMed ID: 18056526
[TBL] [Abstract][Full Text] [Related]
12. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E
Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347
[TBL] [Abstract][Full Text] [Related]
13. [New US guidelines. Myocardial infarct is now treated more aggressively].
MMW Fortschr Med; 2002 May; 144(20):64. PubMed ID: 12119892
[No Abstract] [Full Text] [Related]
14. Clopidogrel in acute coronary syndromes.
Chua D; Ignaszewski A
BMJ; 2009 Apr; 338():b1180. PubMed ID: 19366756
[No Abstract] [Full Text] [Related]
15. Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes.
Di Nisio M; Bijsterveld NR; Meijers JC; Levi M; Büller HR; Peters RJ
J Am Coll Cardiol; 2005 Oct; 46(8):1582-3. PubMed ID: 16226189
[No Abstract] [Full Text] [Related]
16. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
Fefer P; Hod H; Hammerman H; Segev A; Beinart R; Boyko V; Behar S; Matetzky S
Am J Cardiol; 2009 Aug; 104(4):514-8. PubMed ID: 19660604
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?
O'Donoghue M; Wiviott SD
Circulation; 2006 Nov; 114(22):e600-6. PubMed ID: 17130347
[No Abstract] [Full Text] [Related]
19. The loading dose of clopidogrel in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty.
Lin GM; Han CL
Am J Emerg Med; 2010 Mar; 28(3):382-3. PubMed ID: 20223400
[No Abstract] [Full Text] [Related]
20. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
